Search clinical trials for: Altace

Total 831 results

Shanghai Zhongshan Hospital

Unknown

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Carcinoma, Hepatocellular

China
Sherief Abd-Elsalam
Tanta University

Unknown

Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC

Liver Cancer

Egypt
Tianjin Medical University Cancer Institute and...

Not yet recruiting

H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis

Portal Vein Thrombosis | Primary Hepatocellular Carcinoma
Yale University

Completed

Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer

Liver Cancer

United States
Vanderbilt University
National Institutes of Health (NIH)

Completed

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

Metabolic Syndrome
National Institute of Allergy and Infectious Diseases...
Sanofi; GlaxoSmithKline; Bill and Melinda Gates Foundation

Completed

Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa (HVTN702)

HIV Infections

South Africa
University Hospital, Limoges

Completed

Assessment of an Automated Telesurveillance System on the Incidence of Serious Falls in Nursing Homes (TELEHPAD)

The Elderly of 75 Years and Living in Nursing Homes

France
Amgen

Completed

Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors

Advanced Solid Tumors
RWTH Aachen University

Not yet recruiting

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma (ASTrH)

Hepatocellular Carcinoma Non-resectable
Fudan University

Not yet recruiting

cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria

Hepatocellular Carcinoma
Fudan University

Recruiting

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Tang-Du Hospital
Xijing Hospital; Sun Yat-sen University; Shaanxi Provincial People's Hospital; Air... and other collaborators

Completed

A New Conception About Individualized Treatment Allocation for HCC (PTA4HCC)

HCC | Resection | Transarterial Chemoembolization
Shanghai Zhongshan Hospital

Enrolling by invitation

M-TACE Treatment for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Instituto de Investigación Sanitaria de la Fundación...

Completed

Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC

Hepatocellular Carcinoma

Spain
Surefire Medical, Inc.

Terminated

DEB-TACE for Hepatocellular Carcinoma (QED)

Hepatocellular Carcinoma

United States
Nanfang Hospital of Southern Medical University

Unknown

Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

Liver Failure | Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital

Unknown

Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System

Hepatocellular Carcinoma

China
Jinan Military General Hospital

Recruiting

The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma Non-resectable

China
RenJi Hospital
Boston Scientific Corporation

Not yet recruiting

DEB-TACE Prior to Liver Transplantation in the Treatment of HCC

Liver Cancer
Regina Elena Cancer Institute

Recruiting

Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment (AATF/Che-1)

Multiple Myeloma

Italy
Abramson Cancer Center at Penn Medicine
TriSalus Life Sciences

Recruiting

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery (Trinav)

Hepatocellular Carcinoma | Neuroendocrine Tumors

United States
Xuhua Duan

Not yet recruiting

A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
WenBo Guo

Recruiting

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy (ROSE)

Hepatocellular Carcinoma | Regorafenib | Transcatheter Arterial ChEmoembolization

China
Shanghai Zhongshan Hospital

Not yet recruiting

Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE

Hepatocellular Carcinoma Stage III
Fudan University

Recruiting

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Patients With Advanced Hepatocellular Carcinoma (TASK-02)

Hepatocellular Carcinoma

China
Sun Yat-sen University
Ministry of Health, China

Unknown

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion (MDTforHCC)

Hepatocellular Carcinoma

China
National Institute of Allergy and Infectious Diseases...

Completed

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

HIV Infections

United States
French National Agency for Research on AIDS and...
Aventis Pharmaceuticals

Terminated

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

HIV Infection
University of Copenhagen
Hvidovre University Hospital

Unknown

The Endocrine Colon in Humans (Colon)

Healthy

Denmark
Cardiology Research UBC

Terminated

Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD (SAFER-SCAD)

Coronary Artery Dissection, Spontaneous

Canada
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Sherief Abd-Elsalam
Tanta University

Recruiting

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Liver Cancer

Egypt
First Hospital of China Medical University
Xijing Hospital; Sun Yat-sen University; Fudan University; Zhongda Hospital

Unknown

Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC (SEATH)

Carcinoma, Hepatocellular

China
Wuhan Union Hospital, China

Recruiting

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Hepatocellular Carcinoma

China
Jinglong Chen

Recruiting

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

TACE-HAIC vs. HAIC for Potentially Resectable HCC

Hepatocellular Carcinoma | Potentially Resection

China
First Affiliated Hospital Xi'an Jiaotong University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Active, not recruiting

Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence (ALTER-H-004)

Hepatocellular Carcinoma | Anlotinib | TACE

China
Alexander Kim
Surefire Medical, Inc.

Unknown

Surefire Institutional DEB-TACE

Hepatocellular Carcinoma

United States
National Institute of Allergy and Infectious Diseases...
MRC/UVRI and LSHTM Uganda Research Unit; Fogarty International Center of the... and other collaborators

Completed

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

HIV Infections

Uganda
Kronoberg County Council
Malmö University

Completed

Stability of Maxillary Anterior Teeth After Two Years of Retention in Adolescents Comparing Two Bonded and a Vacuum-formed Retainer

Orthodontic Appliance Complication
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Healthy

United States
Novartis Pharmaceuticals

Completed

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

Urogenital Neoplasms | Genital Neoplasms, Male | Prostatic Diseases | Antineoplastic Agents | Imatinib | Prostatic Neoplasm | Genital Diseases, Male | Neoplasms, Abdominal

Germany
Terumo Europe N.V.

Withdrawn

BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study. (BIOPEARL-FIRST)

Hepatocellular Carcinoma

Belgium
Chinese PLA General Hospital

Unknown

Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC

Hepatocellular Carcinoma

China
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Advanced Liver Cancer | Precision Cell Immunotherapy | Transcatheter Arterial Chemoembolization

China
Zhongda Hospital

Recruiting

Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)

Hepatocellular Carcinoma | Portal Hypertension

China
Ming Zhao

Recruiting

TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma

Hepatocellular Carcinoma | Chemoembolization, Therapeutic | Ablation Techniques, RFA

China
Medical College of Wisconsin
Northwestern University; Guerbet

Completed

Can Quantitative MRI After cTACE Help Predict Survival ?

Hepatocellular Carcinoma (HCC)

United States
Guangdong Provincial People's Hospital

Completed

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Hepatocellular Carcinoma | Circulating Tumor Cell;

China

3

Subscribe